Evaluation of Gliomas Peritumoral Diffusion and Prediction of IDH1 Mutation by IVIM-DWI

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2021 Apr 2

PMID 33795525

Citations 2

Authors

Taifu Gu

Ting Yang

Jianglong Huang

Jianhua Yu

Hongxin Ying

XinLan Xiao

Affiliations

Soon will be listed here.

Abstract

Glioma characterized by high morbidity and mortality, is one of the most common brain tumors. The application of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in differentiating glioma grading and IDH1 mutation status were poorly investigated. 78 glioma patients confirmed by pathological and imaging methods were enrolled. Glioma patients were measured using IVIM-DWI, then related parameters such as cerebral blood flow (CBF), perfusion fraction (f), pseudo diffusivity (D*), and true diffusivity (D), were derived. Receiver operating characteristic (ROC) curves were made to calculate specificity and sensitivity. The values of CBF1, CBF3, D*1, rCBF1-2, rCBF3-2, and age in group high-grade gliomas (HGG) were significantly higher than that of in group low-grade gliomas (LGG). The values of CBF1, CBF3, rCBF1-2, rCBF3-2, D*1, and age in group IDH1 were significantly lower than that of in group IDH1. The levels of D1 and f1 were remarkably higher in the group IDH1 than group IDH1. rCBF1-2 had a remarkably positive correlation with CBF1 (r=0.852, p<0.001). f1 showed a markedly negative correlation with CBF1 (r= -0.306, p=0.007). IVIM-DWI presented efficacy in differentiating glioma grading and IDH1 mutation status.

Citing Articles

Comparison of the monoexponential and biexponential models of diffusion-weighted magnetic imaging in grading clear-cell renal cell carcinoma: a case-control study.

Cao J, Dong J, Su G, Zhang B, Zhu L, Wang M Transl Androl Urol. 2024; 13(5):792-801.

PMID: 38855592 PMC: 11157396. DOI: 10.21037/tau-24-141.

Heterogeneity matching and IDH prediction in adult-type diffuse gliomas: a DKI-based habitat analysis.

Liu Y, Wang P, Wang S, Zhang H, Song Y, Yan X Front Oncol. 2023; 13:1202170.

PMID: 38090477 PMC: 10713834. DOI: 10.3389/fonc.2023.1202170.

References

Federau C, Maeder P, OBrien K, Browaeys P, Meuli R, Hagmann P . Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology. 2012; 265(3):874-81. DOI: 10.1148/radiol.12120584. View

Whitfield G, Kennedy S, Djoukhadar I, Jackson A . Imaging and target volume delineation in glioma. Clin Oncol (R Coll Radiol). 2014; 26(7):364-76. DOI: 10.1016/j.clon.2014.04.026. View

Wu G, Liu X, Xiong Y, Ran J, Li X . Intravoxel incoherent motion and diffusion kurtosis imaging for discriminating soft tissue sarcoma from vascular anomalies. Medicine (Baltimore). 2018; 97(50):e13641. PMC: 6320121. DOI: 10.1097/MD.0000000000013641. View

Shen N, Zhao L, Jiang J, Jiang R, Su C, Zhang S . Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion. J Magn Reson Imaging. 2016; 44(3):620-32. DOI: 10.1002/jmri.25191. View

Kang M, Kim M, Oh J, Kim Y, Song S, Seo S . Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer. 2009; 125(2):353-5. DOI: 10.1002/ijc.24379. View

Amukotuwa S, Yu C, Zaharchuk G . 3D Pseudocontinuous arterial spin labeling in routine clinical practice: A review of clinically significant artifacts. J Magn Reson Imaging. 2015; 43(1):11-27. DOI: 10.1002/jmri.24873. View

Xiao Z, Zhong Y, Tang Z, Qiang J, Qian W, Wang R . Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status. Eur Radiol. 2018; 28(7):2923-2933. DOI: 10.1007/s00330-017-5286-x. View

Federau C, Cerny M, Roux M, Mosimann P, Maeder P, Meuli R . IVIM perfusion fraction is prognostic for survival in brain glioma. Clin Neuroradiol. 2016; 27(4):485-492. DOI: 10.1007/s00062-016-0510-7. View

Zhou W, Yu X, Sun S, Zhang X, Yang W, Zhang J . Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence. Biomed Pharmacother. 2019; 118:109369. DOI: 10.1016/j.biopha.2019.109369. View

10.

Wang C, Dong H . Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging. Acta Radiol. 2019; 61(8):1057-1063. DOI: 10.1177/0284185119891694. View

11.

Abrigo J, Fountain D, Provenzale J, Law E, Kwong J, Hart M . Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Cochrane Database Syst Rev. 2018; 1:CD011551. PMC: 6491341. DOI: 10.1002/14651858.CD011551.pub2. View

12.

Jeraj R, Bradshaw T, Simoncic U . Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy. J Nucl Med. 2015; 56(11):1752-65. DOI: 10.2967/jnumed.114.141424. View

13.

Liu Z, Yan L, Hu Y, Sun Y, Tian Q, Nan H . Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial. BMC Med Imaging. 2017; 17(1):10. PMC: 5286785. DOI: 10.1186/s12880-017-0183-y. View

14.

Chen H, Judkins J, Thomas C, Wu M, Khoury L, Benjamin C . Mutant IDH1 and seizures in patients with glioma. Neurology. 2017; 88(19):1805-1813. PMC: 5419985. DOI: 10.1212/WNL.0000000000003911. View

15.

Zhu S, Wei Y, Gao F, Li L, Liu Y, Huang Z . Esophageal carcinoma: Intravoxel incoherent motion diffusion-weighted MRI parameters and histopathological correlations. J Magn Reson Imaging. 2018; 49(1):253-261. DOI: 10.1002/jmri.26172. View

16.

Nayak L, Reardon D . High-grade Gliomas. Continuum (Minneap Minn). 2017; 23(6, Neuro-oncology):1548-1563. DOI: 10.1212/CON.0000000000000554. View

17.

Yamashita A, da Costa Rosa M, Borodovsky A, Festuccia W, Chan T, Riggins G . Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide. Neuro Oncol. 2018; 21(2):189-200. PMC: 6374765. DOI: 10.1093/neuonc/noy146. View

18.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A . Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008; 116(6):597-602. DOI: 10.1007/s00401-008-0455-2. View

19.

Barath K, Huber A, Stampfli P, Varga Z, Kollias S . Neuroradiology of cholesteatomas. AJNR Am J Neuroradiol. 2010; 32(2):221-9. PMC: 7965719. DOI: 10.3174/ajnr.A2052. View

20.

Fukumura D, Jain R . Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res. 2007; 74(2-3):72-84. PMC: 2100036. DOI: 10.1016/j.mvr.2007.05.003. View